
Blog|Articles|May 13, 2010
- Psychiatric Times Vol 27 No 5
- Volume 27
- Issue 5
A Psychiatrist’s Guitar Poem
Author(s)Richard M. Berlin, MD
Hear the story of wood...
Advertisement
Hear the story of wood,
cut and stained
and carved for someone’s need.
Caress the smooth neck
a palm can praise.
Smell mahogany
shaved and steamed,
fragrant as cinnamon.
Rake, slide, bend
tense strings,
make them breathe
each note.
Follow silver steel
over the bridge
from body to head,
each cord vibrating
when skilled hands
and callused fingertips
pick sweet equations
where practice becomes song.
Listen for a minor key,
all the patience and flesh
in the finish,
like a man
in my office
composing a life.
Articles in this issue
over 16 years ago
Get the Bigger Therapeutic Pictureover 16 years ago
Ethical Aspects of Self-Disclosure in Psychotherapyover 16 years ago
Introduction: Ethical Dilemmas Old and Newover 16 years ago
Undue Pharmaceutical Influence on Psychiatric Practiceover 16 years ago
DSM5 and the Medicalization of Grief: Two Perspectivesover 16 years ago
Extraordinarily Ordinaryover 16 years ago
The Political Diagnosis: Psychiatry in the Service of the Lawover 16 years ago
The Fort Hood Aftermath-Army Accountability Review and Psychiatristsover 16 years ago
Memory Reconsolidation and What Albert Ellis Knew All AlongAdvertisement
Related to this article

Courts cite teen brain science to soften sentences; experts warn generalized neuroscience overreaches and adult responsibility stabilizes by 18 to 20.

Can hormones flag suicide risk in schizophrenia? Review links cortisol, thyroid and testosterone shifts—and clozapine/lithium pathways—to risk.

How VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.

RADIANT phase 2 shows once-daily remlifanserin eases Alzheimer’s psychosis symptoms with placebo-like safety, advancing pivotal trials.

Discover how integrated psychotherapy—CBTp, family support, and relapse plans—boosts schizophrenia recovery alongside antipsychotics.

FDA grants Breakthrough Device status to NET Recovery’s tACS wearable, aiming to curb cocaine and meth use and close a major treatment gap.

Learn how IPV shapes mental health from pregnancy to adulthood, and how clinicians assess risk, plan safety, and treat victims and perpetrators.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Treating PTSD Among Veterans at Risk for Suicide
2
FDA Grants Breakthrough Device Designation to NET Recovery's Device for Stimulant Use Disorder
3
Podcast: Not Always Panic. A Cardiologist and Psychiatrist on Reading a Racing Heart
4
Positive Phase 1b Results Demonstrate Clinical Proof-of-Concept for ALKS 7290 in Adults With ADHD
5

